|
Status |
Public on Dec 31, 2021 |
Title |
Gene expression in human recurrent glioblastoma before and after inoculation with the oncolytic herpes simplex virus G207 |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by high throughput sequencing Other
|
Summary |
This SuperSeries is composed of the SubSeries listed below.
|
|
|
Overall design |
Refer to individual Series
|
|
|
Citation(s) |
35105718 |
Submission date |
Dec 31, 2020 |
Last update date |
Feb 23, 2022 |
Contact name |
Katherine E Miller |
E-mail(s) |
katherine.miller@nationwidechildrens.org
|
Organization name |
Nationwide Children's Hospital
|
Department |
Institute for Genomic Medicine
|
Street address |
700 Children's Dr.
|
City |
Columbus |
State/province |
OH |
ZIP/Postal code |
43215 |
Country |
USA |
|
|
Platforms (3) |
GPL10999 |
Illumina Genome Analyzer IIx (Homo sapiens) |
GPL19965 |
nCounter PanCancer Immune Profiling Panel |
GPL20301 |
Illumina HiSeq 4000 (Homo sapiens) |
|
Samples (19)
|
|
This SuperSeries is composed of the following SubSeries: |
GSE162643 |
RNA-sequencing of human glioblastoma resected tissue before and after inoculation with G207, an oncolytic herpes simplex virus; tissues from a Phase Ib clinical trial |
GSE164104 |
Gene expression in human recurrent glioblastoma before and after inoculation with the oncolytic herpes simplex virus G207 using NanoString pancancer immune profiling gene expression panel |
|
Relations |
BioProject |
PRJNA688903 |